Get started
Author

A. Sobrero

Improved Therapeutic Index of Cisplatin by Procaine Hydrochloride
1990 · M. Esposito, R. A. Fulco, et al. · JNCI Journal of the National Cancer Institute · 29
Current Strategies to Reduce Cisplatin Toxicity
1990 · A. Sobrero, A. Guglielmi, et al. · Journal of Chemotherapy · 18
A Randomized Trial of 5-Fluorouracil Alone Versus 5-Fluorouracil and High Dose Leucovorin in Untreated Advanced Colorectal Cancer Patients
1988 · M. T. Nobile, L. Canobbio, et al. · Advances in experimental medicine and biology · 17
Phase 3 Correct Trial of Regorafenib in Metastatic Colorectal Cancer (MCRC): Overall Survival Update
2012 · E.J.D. Van Cutsem, A. Grothey, et al. · Annals of Oncology · 6
6584 A phase III study of CapeOx +/− lapatinib in HER2 positive locally-advanced/metastatic upper gastrointestinal adenocarcinoma: interim safety results
2009 · J. Hecht, Y. Bang, et al. · European Journal of Cancer Supplements · 6
Very high dose cis-platinum (450 mg/sq m) in an infant with rhabdomyosarcoma.
1989 · R Haupt, G Perin, et al. · PubMed · 6
Sidedness influences prognosis in colon cancer patients receiving an adjuvant therapy. A GISCAD analysis from three randomized trials including 5234 patients
2017 · F. Gelsomino, V. Torri, et al. · Annals of Oncology · 4
PDF
Capecitabine (X) vs. bolus 5-FU/LV as adjuvant chemotherapy for patients (pts) with Dukes’ C colon cancer: economic evaluation in an Italian hospital setting
2006 · F. Di Costanzo, A. Sobrero, et al. · Journal of Clinical Oncology · 3
[Surgical resection of gastrointestinal stromal tumor after treatment with imatinib: clinical case].
2005 · S Baldo, M Rivoire, et al. · PubMed · 1
Phase 1 study of first-in-class dUTPase inhibitor, TAS-114 in combination with S-1 in patients with advanced solid tumors
2016 · T. Aoyama, A. Fasolo, et al. · European Journal of Cancer
Subgruppenanalyse von Patienten mit metasiertem kolorektalen Karzinom (mKRK), die unter Regorafenib (REG) in der CORRECT-Studie ein progressionsfreies Überleben von mehr als 4 Monaten hatten
2015 · M Karthaus, A Grothey, et al. · Zeitschrift für Gastroenterologie
Pursuing the No Evidence of Disease Condition in Advanced Colorectal Cancer
2012 · T. Rizzo, A. Sobrero · MD Conference Express
Pursuing the NED Condition in Advanced Colorectal Cancer: Implications for Clinical Practice and Trial Design
2012 · A. Sobrero, A.A. Cogoni · Annals of Oncology
PDF
The Need for a New Fluoropyrimidine in Advanced Gastric Cancer Treatment
2012 · Eric Van Cutsem, Daniel G Haller, et al. · European Oncology & Haematology
319 INVITED Neoadjuvant Treatment in Colon Cancer
2011 · A. Sobrero, M. Di Benedetto · European Journal of Cancer
Optimal safety profile and anticancer activity of NGRhTNF coupled with doxorubicin (NGR003 modified phase I combo trial)
2007 · G. Rizzardi, V. Gregorc, et al. · Journal of Clinical Oncology
Adjuvant therapies in patients with colorectal cancer: An audit on clinical practice in Italy
2004 · F. Roila, B. Ruggeri, et al. · Journal of Clinical Oncology
Prospective evaluation of patients' preferences of three different regimens in a phase II study of FU, oxaliplatin, mitomycin C and CPT-11 in advanced colorectal cancer
2004 · A. Guglielmi, M. Cirillo, et al. · Journal of Clinical Oncology
Adjuvant chemotherapy with fluorouracil and levamisole alone or in combination with 6-S-leucovorin for the treatment of colon cancer: randomized multicenter trial of the Italian Intergroup (INTACC)
2003 · Francesco Di Costanzo, A. Sobrero, et al. · CINECA IRIS Institutial research information system (University of Pisa)
[Treatment of metastatic breast carcinoma].
1999 · F Puglisi, A Sobrero · PubMed
The clinical management of early and advanced colorectal cancer.
1997 · Grossi, Sobrero · PubMed
Standard indication of immunotherapy for the treatnent of cancer
1992 · E. Boli, L. Tina, et al. · Pharmacological Research
Works count: 22
Citation count: 90
H-index: 6
I10-index: 3
Year
Topic
Type